Latest filing published 07 May 2024 for PROCEPT BioRobotics Corp. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Filings by R. Kent McGaughy Jr. span 4 companies, the busiest being PROCEPT BioRobotics Corp, Apollo Endosurgery, Inc. and Reata Pharmaceuticals Inc. Over a trading history stretching from 15 October 2021 to 3 May 2024, the count stands at 11 filings.
Purchases make up the whole of the open-market record (1 purchase, €259k). Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay.
The record was last updated on 7 May 2024 with a transaction in PROCEPT BioRobotics Corp. The most recent open-market purchase was published on 19 October 2021, 1,825 days ago. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. US insiders must file a Form 4 within two business days of a trade. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
11 of 11 declarations